Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079378 | SCV000111250 | benign | not specified | 2013-09-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000079378 | SCV000171407 | benign | not specified | 2013-10-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000079378 | SCV000204494 | benign | not specified | 2013-10-21 | criteria provided, single submitter | clinical testing | Ser767Ser in exon 21 of RYR2: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 2.6% (15/572) of Asi an chromosomes by the 1000 Genomes Project (dbSNP rs117588730). Ser767Ser in ex on 21 of RYR2 (rs117588730; allele frequency = 2.6%, 15/572) |
Invitae | RCV001093913 | SCV000285712 | benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000079378 | SCV000306048 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV001093913 | SCV000356245 | benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000383237 | SCV000356246 | likely benign | Arrhythmogenic right ventricular dysplasia 2 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000588457 | SCV000697614 | benign | not provided | 2016-11-14 | criteria provided, single submitter | clinical testing | Variant summary: The RYR2 c.2301G>T (p.Ser767Ser) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a damaging outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in 306/120764 control chromosomes (7 homozygotes), predominantly observed in the East Asian subpopulation at a frequency of 0.0344308 (297/8626). This frequency is about 1377 times the estimated maximal expected allele frequency of a pathogenic RYR2 variant (0.000025), strong evidence that this is a benign polymorphism found primarily in the populations of East Asian origin. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. The variant of interest has not, to our knowledge, been reported in affected individuals via publications nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign. |
Ambry Genetics | RCV000618616 | SCV000734911 | benign | Cardiovascular phenotype | 2016-06-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000769776 | SCV000901201 | benign | Cardiomyopathy | 2016-04-26 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000769776 | SCV000910756 | benign | Cardiomyopathy | 2018-03-15 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003997204 | SCV004814610 | benign | Catecholaminergic polymorphic ventricular tachycardia | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000079378 | SCV001921977 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000079378 | SCV001956334 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000079378 | SCV001974608 | benign | not specified | no assertion criteria provided | clinical testing |